Brief: Passage Bio Provides Update On Strategic Priorities, Extends Cash Runway

Passage Bio

15/03/2022 11:12

March 15 (Reuters) - Passage Bio Inc  PASG.O :
    * PASSAGE BIO PROVIDES UPDATE ON STRATEGIC PRIORITIES AND
EXTENDS
CASH RUNWAY
    * PASSAGE BIO INC - TO REDUCE WORKFORCE AND PRIORITIZE
RESEARCH
AND DEVELOPMENT PROGRAMS TO REDUCE OPERATING EXPENSES
    * PASSAGE BIO INC - ESTIMATED CASH RUNWAY EXTENDED INTO Q2
2024
    * PASSAGE BIO INC - WILL DECREASE OPERATING EXPENSES BY
REDUCING
WORKFORCE BY APPROXIMATELY 13 PERCENT
    * PASSAGE BIO INC - CONTINUED FOCUS ON EXECUTION OF THREE
ONGOING
CLINICAL TRIALS FOR GM1 GANGLIOSIDOSIS, KRABBE DISEASE AND
FRONTOTEMPORAL DEMENTIA
    * PASSAGE BIO - WILL DECREASE OPERATING EXPENSES BY
PRIORITIZING
ITS RESEARCH, DEVELOPMENT PROGRAMS IN PARTNERSHIP WITH
UNIVERSITY OF PENNSYLVANIA'S GTP

Source text for Eikon:  ID:nGNX6thFtz 
Further company coverage:  PASG.O